Vaccine News and Research

Latest Vaccine News and Research

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.

2 Apr 2018

New $3.2 million grant funds research to advance promising malaria vaccine

The Global Health Innovative Technology Fund has awarded the University of Florida and partners in the United States and Japan $3.2 million to advance a promising vaccine to prevent transmission of malaria.

29 Mar 2018

Phase I clinical trial of HIV vaccines to begin in the U.S.

A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.

28 Mar 2018

FDA-approved inhibitors could be repurposed to target ARID1A-mutant ovarian cancers

Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the treatment of diseases such as leukemia, as a new therapeutic option for ovarian cancer with mutations in the ARID1A gene.

27 Mar 2018

Novel vaccine technologies can help better prepare for future infectious disease threats

Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

22 Mar 2018

Targeting aberrantly active telomerase to treat therapy-resistant melanoma

A study conducted at The Wistar Institute in collaboration with The University of Texas Southwestern Medical Center has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma.

21 Mar 2018

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech S.A., a leading international technology partner of the biopharmaceutical industry, has been selected by ABL Europe as its primary supplier of single-use systems.

From Sartorius 21 Mar 2018

Research misconduct allegations shadow likely CDC appointee

A more than 20-year-old controversy over shoddy HIV research is re-emerging as a significant criticism of President Donald Trump's likely pick to lead the Centers for Disease Control and Prevention.

21 Mar 2018

Researchers identify new treatment targets for lung diseases using big data

Every year, approximately 12 million adults in the U.S. are diagnosed with Chronic Obstructive Pulmonary Disease, and 120,000 die from it. For people with COPD, Haemophilus influenzae, a bacterium, can be particularly dangerous.

20 Mar 2018

Adults skipping vaccines may miss out on effective new shingles shot

Federal officials have recommended a new vaccine that is more effective than an earlier version at protecting older adults against the painful rash called shingles. But persuading many adults to get this and other recommended vaccines continues to be an uphill battle, physicians and vaccine experts say.

20 Mar 2018

Measles alert after two passengers with the disease fly into US

Vulnerable persons who have not been vaccinated for measles and have been through airports in Newark, New Jersey, Detroit and Memphis this month are being warned about the possible risk of measles by the health officials. They have announced that two air passengers from overseas were confirmed to have had measles and were travelling via these airports.

18 Mar 2018

Yellow fever outbreak in Brazil necessitates vaccination for travelers

Brazil is in the midst of a yellow fever outbreak, with the mosquito-borne virus reaching popular tourist destinations that do not normally see the disease. Since January 2018, 10 cases of yellow fever have been confirmed in international travelers visiting Brazil, including four deaths.

16 Mar 2018

Climate change spurs proliferation of disease-bearing insects, increases exposure to viral infections

Scientists at the Joint Research Centre, the European Commission's science and knowledge service, find that global warming has allowed disease-bearing insects to proliferate, increasing exposure to viral infections.

16 Mar 2018

Misconceptions about MMR vaccine found to influence usage of Zika vaccine

People's willingness to use a Zika vaccine when it's available will be influenced by how they weigh the risks associated with the disease and the vaccine, but also by their misconceptions about other vaccines, a new study has found.

15 Mar 2018

Researchers explore whether MERS-CoV is a threat for Africa

Middle East respiratory syndrome (MERS) is a lethal disease in humans, caused by a coronavirus (MERS-CoV). It was first identified in man in 2012, in the Arabian Peninsula.

15 Mar 2018

Participants in rogue herpes vaccine research take legal action

Three people injected with an unauthorized herpes vaccine by a Southern Illinois University researcher have filed suit against his company, demanding compensation for alleged adverse side effects from the experiments.

13 Mar 2018

ACEA launches comprehensive and searchable online library of xCELLigence papers

In 2002 ACEA Biosciences pioneered real-time cellular impedance as a tool for dynamically tracking cell number, cell size, cell-substrate attachment strength, and cell invasion/migration.

13 Mar 2018

Transformative new approach for viral titer determination using xCELLigence RTCA

Accurate determination of viral titers is critical to vaccine development. Historically, titers have been determined using endpoint assays which are labor-intensive, expensive, and time-consuming. This is increasingly problematic in modern production facilities where bioprocess optimization is performed using high-throughput cell culture reactors that can produce batches of virus faster than they can be analyzed.

13 Mar 2018

Team-based game decreases hyperactivity and problem behavior in kids

A game that encourages good behavior, positive reinforcement and self-regulation can keep children on task and out of trouble, according to researchers at the University of Georgia and Pennsylvania State University.

9 Mar 2018

Groundbreaking discoveries pave way for fast-acting antidote to tackle cholera epidemics

Groundbreaking discoveries regarding the onset of cholera are paving the way for a future, fast-acting antidote for cholera epidemics, according to research published in the journals PLOS Pathogens and ACS Infectious Disease.

9 Mar 2018